Global Cardiac Surgery Market to Hit $24.9B by 2030, Challenging Pharmaceuticals & Interventional Cardiology

April 22, 2024 03:15 PM BST | By EIN Presswire
 Global Cardiac Surgery Market to Hit $24.9B by 2030, Challenging Pharmaceuticals & Interventional Cardiology
Image source: EIN Presswire

VANCOUVER, BC, CANADA, April 22, 2024 /EINPresswire.com/ -- iData Research, a renowned global consulting and market research firm specializing in the medical device, dental, and pharmaceutical sectors, has released its 2024 report on the Global Cardiac Surgery Market.

This comprehensive report of almost 1500 pages offers an in-depth analysis of procedure volume by market segment for over 65 countries world-wide, including tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair, transcatheter heart valve replacement, cerebral embolic protection devices, balloon valvuloplasty, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, autotransfusion devices, endoscopic vessel harvesting devices, anastomosis assist devices, ventricular assist devices, intra-aortic balloon devices, artificial heart replacement devices, patent foramen ovale closure devices, patent ductus arteriosus closure devices, atrial and ventricular septal defect closure devices, left atrial appendage closure devices, preshaped guidewires, transmyocardial revascularization devices and extracorporeal membrane oxygenation (ECMO) markets.

The global cardiac surgery device market has seen great expansion in the last decade with procedural innovations supporting the growing need for surgical interventions. Despite these innovations, most of the market segments maintain their portion of the market due to their niche clinical applications. These innovations are also in competition with developments in other markets such as pharmaceuticals and interventional cardiology.

Key highlights from iData's report include:

Robust Market Expansion: The global cardiac surgery market was valued at $17.1 billion in 2023, and is expected to increase and reach $24.9 billion by 2030.

Transcatheter Mitral Valve Repair: Forecasted growth in the transcatheter mitral valve repair (TMVr) devices market is substantial. These devices, which allow mitral valve repair without traditional open-heart surgery, are anticipated to capture a larger market share due to significant patient demand.

Competitive Landscape: In the global cardiac surgery market, Edwards Lifesciences, Abbott, and Medtronic were the top three market share leaders. Other leading competitors include Abiomed, Boston Scientific, Getinge, LivaNova, Terumo, Gore, Atricure, among others.

For more information on the global cardiac surgery market, visit our report product page:

https://idataresearch.com/product/cardiac-surgery-market/

About iData

iData Research stands out as the premier market research and intelligence provider, offering unparalleled insights and comprehensive data analysis across a multitude of industries. With a strong reputation and a proven track record, iData Research has solidified its position as the best choice for businesses seeking to make informed decisions in today's dynamic market landscape.

Why Should You Choose iData?

Extensive Industry Coverage: iData Research boasts an impressive range of industry coverage, spanning healthcare, medical devices, dental, pharmaceuticals, biotechnology, and more. This breadth of coverage ensures that clients from various sectors can access accurate, up-to-date information relevant to their business goals.

High-Quality Data: The cornerstone of iData Research's success is its commitment to providing high-quality data. Their team of expert analysts employs rigorous methodologies to collect and analyze data from reliable sources. This ensures that clients receive accurate, insightful, and actionable information to guide their strategic decisions.

In-Depth Analysis: iData Research goes beyond mere data presentation by offering in-depth analysis that goes right to the heart of industry trends, market dynamics, and competitive landscapes. Their reports provide a holistic understanding of market forces, helping clients identify opportunities and challenges.

Customized Solutions: Recognizing that every business is unique, iData Research offers customizable solutions that cater to specific client needs. Whether it's a small startup or a multinational corporation, their tailored offerings provide the right insights to drive growth and success.

Timely Updates: Staying ahead in today's fast-paced business environment requires access to real-time information. iData Research ensures that its clients are equipped with the latest data and insights, enabling them to make agile decisions and adapt to market changes swiftly.

Global Perspective: In an increasingly interconnected world, having a global perspective is essential. iData Research's reports provide insights into various geographic markets, enabling clients to make informed decisions regardless of their business's location.

Trusted by Industry Leaders: The fact that iData Research is trusted by industry leaders and renowned companies speaks volumes about the quality of their services. Their client list includes major players who rely on their insights for strategic planning.

Emma Matrick
iData Research
+17785493830 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next